P1RG34 Stock Overview
Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 3/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 4/6 |
Perrigo Company plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$153.30 |
| 52 Week High | US$167.79 |
| 52 Week Low | US$130.53 |
| Beta | 0.65 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | -34.15% |
| 5 Year Change | n/a |
| Change since IPO | -38.14% |
Recent News & Updates
Recent updates
Shareholder Returns
| P1RG34 | BR Pharmaceuticals | BR Market | |
|---|---|---|---|
| 7D | 0% | 2.0% | 0.4% |
| 1Y | n/a | -15.4% | 13.9% |
Return vs Industry: Insufficient data to determine how P1RG34 performed against the BR Pharmaceuticals industry.
Return vs Market: Insufficient data to determine how P1RG34 performed against the BR Market.
Price Volatility
| P1RG34 volatility | |
|---|---|
| P1RG34 Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 5.5% |
| Market Average Movement | 4.7% |
| 10% most volatile stocks in BR Market | 8.8% |
| 10% least volatile stocks in BR Market | 2.3% |
Stable Share Price: P1RG34 has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine P1RG34's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1887 | 9,140 | Patrick Lockwood-Taylor | www.perrigo.com |
Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers.
Perrigo Company plc Fundamentals Summary
| P1RG34 fundamental statistics | |
|---|---|
| Market cap | R$21.79b |
| Earnings (TTM) | -R$22.65m |
| Revenue (TTM) | R$23.96b |
0.9x
P/S Ratio-961.9x
P/E RatioIs P1RG34 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| P1RG34 income statement (TTM) | |
|---|---|
| Revenue | US$4.66b |
| Cost of Revenue | US$2.98b |
| Gross Profit | US$1.68b |
| Other Expenses | US$1.68b |
| Earnings | -US$4.40m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 07, 2024
| Earnings per share (EPS) | -0.032 |
| Gross Margin | 36.09% |
| Net Profit Margin | -0.094% |
| Debt/Equity Ratio | 85.4% |
How did P1RG34 perform over the long term?
See historical performance and comparison